Identification of additional patient populations susceptible to cryptococcosis, such as those with anti-granulocyte macrophage colony-stimulating factor (GM-CSF) autoantibodies [247,248], may reveal previously unknown immune processes important for the host response to C. neoformans. The gene discussed is CSF2; the disease is cryptococcosis.